Institution
Uppsala University
Also known as: Uppsala universitet · Uppsalan yliopisto
- 11running trials
- 4closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
The site has not confirmed any trial yet.
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- ANCA-associated vasculitis1 recruiting
- Atrial fibrillation1 recruiting
- Childhood cancers1 recruiting
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Depression1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- Lupus (SLE)1 recruiting
- Prostate cancer1 recruiting
- Stroke1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Researchers
No researcher is linked here yet.
Closed trials
Trial sites
- Uppsala Universitet1 trial
- Uppsala University13 trials
- Uppsala University, the Department of Surgical Sciences1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Obesity141 works · 0 trials
- Type 2 diabetes79 works · 0 trials
- Colorectal cancer77 works · 0 trials
- Asthma72 works · 0 trials
- Atrial fibrillation48 works · 1 trials
- Parkinson disease47 works · 0 trials
- COPD33 works · 1 trials
- Rheumatoid arthritis29 works · 0 trials
- Lupus (SLE)22 works · 1 trials
- Childhood cancers19 works · 1 trials
- Long COVID and ME/CFS19 works · 0 trials
- Hodgkin lymphoma18 works · 0 trials
- Neuroendocrine tumours12 works · 0 trials
- Head and neck cancer11 works · 1 trials
- Neuroblastoma10 works · 0 trials
- Diffuse large B-cell lymphoma9 works · 0 trials
- Huntington's disease8 works · 0 trials
- Myasthenia gravis8 works · 1 trials
- Mantle cell lymphoma5 works · 0 trials
- High blood pressure4 works · 1 trials
Institution data: ROR 048a87296 (CC0-1.0)Updated 10 Nov 2026